Results 31 to 40 of about 4,636,278 (309)

Adverse Events of DOACs in Children

open access: yesFrontiers in Pediatrics, 2022
Venous thromboembolism (VTE) has an increasing rate of significance in pediatric patients. The currently standardized anticoagulants (unfractionated heparin, low molecular weight heparin and vitamin K antagonists) and their dose regimens were not ...
Alessandra Bosch   +2 more
doaj   +1 more source

The average cost of measles cases and adverse events following vaccination in industrialised countries. [PDF]

open access: yes, 2002
BACKGROUND: Even though the annual incidence rate of measles has dramatically decreased in industrialised countries since the implementation of universal immunisation programmes, cases continue to occur in countries where endemic measles transmission has
Kou Ulla   +14 more
core   +2 more sources

Adverse events

open access: yesBritish Journal of Surgery, 2004
No room for ...
openaire   +2 more sources

Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization

open access: yesThe Journal of Pediatrics, 2022
To estimate the risk of recurrence of adverse events following immunization (AEFIs) upon revaccination and to determine among patients with suspected vaccine allergy whether allergy skin test positivity was associated with AEFI recurrence.This prospective observational study included patients assessed in the Canadian Special Immunization Clinic Network
Caroline E. Muñoz   +21 more
openaire   +2 more sources

Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy. [PDF]

open access: yes, 2014
Few data describe antiretroviral treatment (ART)-related adverse events when treatment is initiated at CD4 cell counts more than 350 cells/μl.
Chadwick, D   +31 more
core   +1 more source

Prinum non nocere: thoughts on the need to develop an 'adverse events' register for complementary and alternative therapies [PDF]

open access: yes, 2002
Building a body of knowledge to support the eff|cacy and practice of complementary and alternative therapies is an imperative that should be fully embraced by all those involved.
Biley, Francis
core   +1 more source

Public Health Surveillance for Adverse Events Following Covid-19 Vaccination in Africa: Rare Adverse Events and Fatal Cases Following COVID-19 Vaccination in Africa

open access: yes, 2022
Background: The death toll and economic disaster caused by SARS-CoV-2/ COVID-19 is still on the rise globally and in Africa with a case fatality ratio (CFR), 2.58 from 220,958 deaths out of 8,556,890 cases recorded across the continent as of 14th ...
Elelu, Nusirat   +19 more
core   +1 more source

Ovarian Sex Cord Stromal Tumors in Children and Adolescents—The European Standard Clinical Practice Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider   +15 more
wiley   +1 more source

Adverse events in British hospitals: preliminary retrospective record review

open access: yes, 2001
Objectives: To examine the feasibility of detecting adverse events through record review in British hospitals and to make preliminary estimates of the incidence and costs of adverse events.
Neale, G.   +3 more
core   +1 more source

Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks.
Charlotte N. Stahlfeld   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy